✦ LIBER ✦

HIV and HCV Coinfection: Where Are We in 2010?

✍ Scribed by Esperance Schaefer; Raymond T. Chung

Book ID: 107540532
Publisher: Current Science Inc.
Year: 2010
Tongue: English
Weight: 155 KB
Volume: 9
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-010-0045-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic Syndrome and HCV: Where Do We

Metabolic Syndrome and HCV: Where Do We Stand in 2010?

✍ Paul Lamb; Stephen Harrison 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 187 KB

The HCV and HIV coinfected patient: What

The HCV and HIV coinfected patient: What have we learned about pathophysiology?

✍ Andrew H. Talal; P. Wilfredo Canchis; Ira M. Jacobson 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 549 KB

HCV kinetics, quasispecies, and clearanc

HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia

✍ Norah J. Shire; Paul S. Horn; Susan D. Rouster; Sandra Stanford; M. Elaine Eyste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Hepatitis C virus (HCV) treatment response rates remain low in HCV/HIV-1-coinfected individuals compared with those with HCV alone. Persons with inherited coagulation disorders have high rates of HCV and HIV-1 infection, but HCV treatment trials in this patient population are scarce. We hypothesized

HIV and HCV coinfected haemophilia patie

HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?

✍ E. C. RODRIGUEZ-MERCHAN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

Soluble Fas and Fas ligand in HIV/HCV co

Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy

✍ M. Guzmán-Fulgencio; J. Berenguer; M. García-Álvarez; D. Micheloud; J. C. López; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 238 KB

Cellular therapy in multiple sclerosis:

Cellular therapy in multiple sclerosis: where we are and where we are going

✍ G. Martino 📂 Article 📅 2005 🏛 Springer Milan 🌐 English ⚖ 23 KB